Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Beta blockers in stable angina pectoris]

M Fluri1, B Meier

  • 1Departement Medizin, Universitätsklinik, Bern.

Praxis
|March 7, 1995
PubMed
Summary
This summary is machine-generated.

This study reviews stable angina pathophysiology and therapy, including beta-blockers and calcium channel blockers. Clinical trial results sometimes conflict with current models, highlighting areas for further research in angina management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

When conditioned responses "fire back": bidirectional cross-activation creates learning opportunities in synesthesia.

Neuroscience·2007
Same author

Cytokine activation and disease progression in patients with stable moderate chronic heart failure.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2007
Same author

Sex differences in semantic processing: event-related brain potentials distinguish between lower and higher order semantic analysis during word reading.

Cerebral cortex (New York, N.Y. : 1991)·2006
Same author

The effect of genotype and cultivation method on the total salicylate yield of dark-leaved willows (Salix myrsinifolia).

Planta medica·2006
Same author

Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials.

Heart (British Cardiac Society)·2005
Same author

Influence of diabetes mellitus on coronary collateral flow: an answer to an old controversy.

Heart (British Cardiac Society)·2005
Same journal

Praxis·2026
Same journal

[What do Swiss doctors think about cardiovascular risk factors and guidelines?]

Praxis·2026
Same journal

[Laser interstitial thermotherapy (LITT): a minimally invasive neurosurgical treatment option for brain tumours and radiation necrosis].

Praxis·2026
Same journal

[Persistent back pain after lifting trauma. From the trivial to the rare case].

Praxis·2026
Same journal

[A patient with dizziness and gait instability - a diagnostic challenge].

Praxis·2026
Same journal

[Meningoencephalitis caused by listeria monocytogenes].

Praxis·2026
See all related articles

Area of Science:

  • Cardiology
  • Pharmacology
  • Pathophysiology

Context:

  • Stable angina pectoris remains a significant clinical challenge.
  • Understanding its pathophysiologic mechanisms is crucial for effective treatment.
  • Current therapeutic strategies involve beta-adrenergic blockers and calcium entry blockers.

Purpose:

  • To provide an overview of stable angina pathophysiology.
  • To analyze the rationales and mechanisms of beta-adrenergic blockers and calcium entry blockers.
  • To discuss the clinical trial evidence and its correlation with pathophysiological models.

Summary:

  • Examines the pathophysiologic mechanisms underlying stable angina pectoris.
  • Describes the pharmacological actions of beta-adrenergic blockers and calcium entry blockers.

Related Experiment Videos

  • Highlights discrepancies between clinical trial outcomes and existing pathophysiological models.
  • Discusses the combined use of beta-adrenergic blockers and calcium entry blockers.
  • Addresses the prognostic significance of silent ischemia in stable angina.

    • Impact:

    • Informs therapeutic strategies for stable angina pectoris.
    • Identifies potential areas for refining treatment based on clinical evidence.
    • Underscores the importance of considering silent ischemia in patient management.